Table 2.
Standard Morbidity Ratios for county characteristics of the mother's living location at the time of birth. Values are the median and 95% credible sets from the posterior distribution.
| CROPS | HAPS | METRO | URBAN | GROWTH | |
| Acute Lymphoid leukemias (ALL) | 1.01 (0.79, 1.28) |
0.97 (0.76, 1.25) |
1.04 (0.82, 1.36) |
1.11 (0.82, 1.48) |
0.97 (0.82, 1.16) |
| Acute myeloid leukemias (AML) | 0.75 (0.41, 1.27) |
0.81 (0.50, 1.29) |
0.97 (0.61, 1.58) |
1.01 (0.57, 1.84) |
1.22 (0.87, 1.81) |
| Other leukemias | 0.98 (0.50, 1.80) |
0.57 (0.31, 1.02) |
1.26 (0.66, 2.51) |
1.60 (0.73, 3.71) |
0.95 (0.58, 1.50) |
| Hodgkin lymphoma | 1.00 (0.41, 2.36) |
0.81 (0.35, 2.02) |
1.03 (0.49, 2.40) |
1.47 (0.52, 4.96) |
0.49 (0.27, 0.96) |
| Non-Hodgkin lymphoma | 1.02 (0.61, 1.70) |
0.75 (0.48, 1.17) |
1.10 (0.70, 1.77) |
1.16 (0.68, 2.11) |
0.88 (0.63, 1.26) |
| Ependymoma and choroid plexus tumor | 0.56 (0.26, 1.12) |
1.07 (0.59, 1.99) |
0.90 (0.51, 1.60) |
0.97 (0.46, 2.26) |
0.86 (0.54, 1.39) |
| Astrocytomas | 0.97 (0.67, 1.40) |
0.80 (0.57, 1.15) |
1.22 (0.85, 1.78) |
1.07 (0.69, 1.71) |
1.03 (0.79, 1.43) |
| Intracranial and intraspinal embryonal tumors | 0.72 (0.43, 1.24) |
1.12 (0.71, 1.77) |
0.85 (0.55, 1.35) |
1.42 (0.74, 2.80) |
0.99 (0.69, 1.44) |
| Other gliomas | 1.77 (0.98, 3.27) |
1.41 (0.82, 2.54) |
1.23 (0.69, 2.25) |
1.08 (0.48, 2.72) |
1.03 (0.64, 1.69) |
| Other CNS tumors | 1.04 (0.57, 1.83) |
0.94 (0.56, 1.55) |
1.29 (0.78, 2.16) |
0.82 (0.44, 1.65) |
0.82 (0.57, 1.20) |
| Neuroblastoma and other peripheral nervous cell tumors | 1.12 (0.78, 1.60) |
1.15 (0.83, 1.59) |
1.11 (0.81, 1.64) |
0.74 (0.52, 1.09) |
0.93 (0.74, 1.17) |
| Rtinoblastoma | 0.86 (0.50, 1.48) |
1.02 (0.60, 1.60) |
1.22 (0.77, 1.99) |
1.05 (0.58, 2.00) |
0.89 (0.62, 1.32) |
| Renal tumors | 0.95 (0.59, 1.51) |
1.21 (0.80, 1.79) |
1.04 (0.69, 1.61) |
0.98 (0.58, 1.69) |
0.91 (0.66, 1.28) |
| Hepatic tumors | 0.80 (0.32, 1.91) |
1.87 (0.95, 3.98) |
0.99 (0.53, 1.90) |
1.28 (0.46, 4.61) |
1.16 (0.66, 2.18) |
| Malignant bone tumors | 1.31 (0.51, 2.90) |
1.15 (0.55, 2.55) |
0.77 (0.36, 1.75) |
0.67 (0.24, 2.08) |
1.86 (0.89, 4.24) |
| Soft tissue and other extraosseous sarcomas | 1.03 (0.64, 1.59) |
0.86 (0.59, 1.28) |
1.06 (0.70, 1.62) |
1.42 (0.83, 2.57) |
1.04 (0.74, 1.41) |
| Germ cell tumors, trophoblastic tumors, and neoplasms of gonads | 1.54 (0.90, 2.75) |
0.86 (0.50, 1.46) |
1.40 (0.82, 2.64) |
0.87 (0.46, 1.77) |
1.03 (0.66, 1.63) |
| Other malignant epithelial neoplasms and melanomas | 1.25 (0.57, 3.05) |
0.89 (0.42, 1.97) |
1.23 (0.60, 2.87) |
0.98 (0.38, 3.01) |
1.17 (0.66, 2.25) |
| Other and unspecified malignant neoplasms (including uncoded) | 0.85 (0.25, 2.30) |
0.68 (0.25, 1.75) |
1.07 (0.47, 2.88) |
1.17 (0.37, 4.83) |
0.81 (0.37, 1.88) |